Kotsopoulos, Nikos http://orcid.org/0000-0002-8248-7697
Connolly, Mark P. http://orcid.org/0000-0002-1886-745X
Funding for this research was provided by:
Novo Nordisk (0212022)
Article History
Received: 30 August 2023
Accepted: 20 October 2023
First Online: 18 November 2023
Declarations
:
: The work described here has been sponsored by Novo Nordisk. The authors Mark P. Connolly and Nikos Kotsopoulos received funding from the sponsoring organization for their contributions. The authors hold no financial interests in the sponsoring organisation. The authors retained full editorial control over the manuscript content and final published material. The study sponsors were given a chance to review the final manuscript; however, the authors retained full and final editorial control over published content. The authors report no other potential conflicts of interest in relation to this work.
: Ethical approval was not required in relation to this modelling study. The model was constructed from previously published studies that have been cited in the text. No proprietary data, primary clinical data or individual data has been used in this research. No interventions requiring animals or humans are investigated in this study.